Richard Moser to Early Detection of Cancer
This is a "connection" page, showing publications Richard Moser has written about Early Detection of Cancer.
Connection Strength
0.417
-
Mai PL, Huang HQ, Wenzel LB, Han PK, Moser RP, Rodriguez GC, Boggess J, Rutherford TJ, Cohn DE, Kauff ND, Phillips KA, Wilkinson K, Wenham RM, Hamilton C, Powell MA, Walker JL, Greene MH, Hensley ML. Prospective follow-up of quality of life for participants undergoing risk-reducing salpingo-oophorectomy or ovarian cancer screening in GOG-0199: An NRG Oncology/GOG study. Gynecol Oncol. 2020 01; 156(1):131-139.
Score: 0.134
-
Rendle KA, Sarma EA, Quaife SL, Blake KD, Moser RP, Suls JM, Edwards HM, Kobrin SC. Cancer Symptom Recognition and Anticipated Delays in Seeking Care Among U.S. Adults. Am J Prev Med. 2019 07; 57(1):e1-e9.
Score: 0.130
-
Shavers VL, Underwood W, Moser RP. Race/ethnicity, risk perception, and receipt of prostate-specific antigen testing. J Natl Med Assoc. 2009 Jul; 101(7):698-704.
Score: 0.065
-
Johnson JA, Moser RP, Ellison GL, Martin DN. Associations of Prostate-Specific Antigen (PSA) Testing in the US Population: Results from a National Cross-Sectional Survey. J Community Health. 2021 04; 46(2):389-398.
Score: 0.036
-
Mai PL, Piedmonte M, Han PK, Moser RP, Walker JL, Rodriguez G, Boggess J, Rutherford TJ, Zivanovic O, Cohn DE, Thigpen JT, Wenham RM, Friedlander ML, Hamilton CA, Bakkum-Gamez J, Olawaiye AB, Hensley ML, Greene MH, Huang HQ, Wenzel L. Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2017 04; 145(1):122-129.
Score: 0.028
-
Hamilton JG, Breen N, Klabunde CN, Moser RP, Leyva B, Breslau ES, Kobrin SC. Opportunities and challenges for the use of large-scale surveys in public health research: a comparison of the assessment of cancer screening behaviors. Cancer Epidemiol Biomarkers Prev. 2015 Jan; 24(1):3-14.
Score: 0.024